Summary of follow-up
. | Sibling . | VUD . | All . |
|---|---|---|---|
| Median follow-up, all, d (range) | 474 (50-1392) | 295 (37-1495) | 348 (37-1495) |
| Median follow-up, survivors, d (range) | 524 (93-1392) | 420 (53-1495) | 473 (53-1495) |
| Predicted NRM, % | |||
| Day + 100 | 0 | 11 | 7 |
| Day + 200 | 5 | 17 | 13 |
| 1 year | 5 | 21 | 15 |
| Predicted DFS, % | |||
| Day + 100 | 83 | 84 | 84 |
| Day + 200 | 70 | 66 | 67 |
| 1 year | 61 | 59 | 62 |
| Predicted OS, % | |||
| Day + 100 | 92 | 87 | 89 |
| Day + 200 | 79 | 81 | 80 |
| 1 year | 73 | 71 | 74 |
. | Sibling . | VUD . | All . |
|---|---|---|---|
| Median follow-up, all, d (range) | 474 (50-1392) | 295 (37-1495) | 348 (37-1495) |
| Median follow-up, survivors, d (range) | 524 (93-1392) | 420 (53-1495) | 473 (53-1495) |
| Predicted NRM, % | |||
| Day + 100 | 0 | 11 | 7 |
| Day + 200 | 5 | 17 | 13 |
| 1 year | 5 | 21 | 15 |
| Predicted DFS, % | |||
| Day + 100 | 83 | 84 | 84 |
| Day + 200 | 70 | 66 | 67 |
| 1 year | 61 | 59 | 62 |
| Predicted OS, % | |||
| Day + 100 | 92 | 87 | 89 |
| Day + 200 | 79 | 81 | 80 |
| 1 year | 73 | 71 | 74 |